Trial Site Detail
Drug: |
XL228 |
|||
|---|---|---|---|---|
Trial: |
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Duke University |
Principal Investigator: |
Herb Horowttz, MD |
|---|---|
Contact: |
Sharon Norman 919-681-5257 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Duke University Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.